Johnathan M Lancaster - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Johnathan M Lancaster

Showing results (51-60 of 73) with videos related to

Pageof 8

Sort By:

Nature|November 8, 2005

Oncogenic pathway signatures in human cancers as a guide to targeted therapiesAndrea H Bild, Guang Yao, Jeffrey T Chang, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2007

An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancerHolly K Dressman, Andrew Berchuck, Gina Chan, et al.

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 29, 2012

Characterizing the efficacy of fermented wheat germ extract against ovarian cancer and defining the genomic basis of its activityPatricia L Judson, Entidhar Al Sawah, Douglas C Marchion, et al.

Oncology Reports|March 8, 2013

A novel c-Met inhibitor, MK8033, synergizes with carboplatin plus paclitaxel to inhibit ovarian cancer cell growthDouglas C Marchion, Elona Bicaku, Yin Xiong, et al.

Journal of Cancer Research and Clinical Oncology|August 29, 2014

The Chinese herb polyphyllin D sensitizes ovarian cancer cells to cisplatin-induced growth arrestEntidhar Al Sawah, Douglas C Marchion, Yin Xiong, et al.

International Journal of Molecular Medicine|February 6, 2015

BAD-mediated apoptotic pathway is associated with human cancer developmentXiaomang B Stickles, Douglas C Marchion, Elona Bicaku, et al.

International Journal of Oncology|May 4, 2012

The O-glycan pathway is associated with in vitro sensitivity to gemcitabine and overall survival from ovarian cancerNadim Bou Zgheib, Yin Xiong, Douglas C Marchion, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2009

Microarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcomeAndrew Berchuck, Edwin S Iversen, Jingqin Luo, et al.

American Journal of Obstetrics and Gynecology|August 13, 2013

Gene expression data reveal common pathways that characterize the unifocal nature of ovarian cancerDouglas C Marchion, Yin Xiong, Hye Sook Chon, et al.

Molecular and Clinical Oncology|March 22, 2016

Sensitivity of ovarian cancer cells to acetaminophen reveals biological pathways that affect patient survivalStephen H Bush, Sharon Tollin, Douglas C Marchion, et al.

Pageof 8

Search research articles

Showing results (51-60 of 73) with videos related to

Sort By:

Pageof 8

Nature|November 8, 2005

Oncogenic pathway signatures in human cancers as a guide to targeted therapiesAndrea H Bild, Guang Yao, Jeffrey T Chang, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2007

An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancerHolly K Dressman, Andrew Berchuck, Gina Chan, et al.

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 29, 2012

Characterizing the efficacy of fermented wheat germ extract against ovarian cancer and defining the genomic basis of its activityPatricia L Judson, Entidhar Al Sawah, Douglas C Marchion, et al.

Oncology Reports|March 8, 2013

A novel c-Met inhibitor, MK8033, synergizes with carboplatin plus paclitaxel to inhibit ovarian cancer cell growthDouglas C Marchion, Elona Bicaku, Yin Xiong, et al.

Journal of Cancer Research and Clinical Oncology|August 29, 2014

The Chinese herb polyphyllin D sensitizes ovarian cancer cells to cisplatin-induced growth arrestEntidhar Al Sawah, Douglas C Marchion, Yin Xiong, et al.

International Journal of Molecular Medicine|February 6, 2015

BAD-mediated apoptotic pathway is associated with human cancer developmentXiaomang B Stickles, Douglas C Marchion, Elona Bicaku, et al.

International Journal of Oncology|May 4, 2012

The O-glycan pathway is associated with in vitro sensitivity to gemcitabine and overall survival from ovarian cancerNadim Bou Zgheib, Yin Xiong, Douglas C Marchion, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2009

Microarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcomeAndrew Berchuck, Edwin S Iversen, Jingqin Luo, et al.

American Journal of Obstetrics and Gynecology|August 13, 2013

Gene expression data reveal common pathways that characterize the unifocal nature of ovarian cancerDouglas C Marchion, Yin Xiong, Hye Sook Chon, et al.

Molecular and Clinical Oncology|March 22, 2016

Sensitivity of ovarian cancer cells to acetaminophen reveals biological pathways that affect patient survivalStephen H Bush, Sharon Tollin, Douglas C Marchion, et al.

Pageof 8